Comparison of digital pathology AI models, genomics classifier, and clinical variables in predicting progression free survival in TCGA prostate data set. Absence of prostate cancer events after 3 ...
The CAPTAIN trial compared the MRI-Guided TULSA Procedure™ to robotic radical prostatectomy for localized prostate cancer.
An MRI before treatment in men undergoing radical prostatectomy can provide independent prognostic value for oncologic ...
Robot-assisted radical prostatectomy outcomes are comparable across ages. Find out why older patients can safely undergo RARP. Read more.
Stereotactic body radiotherapy as salvage therapy after radical prostatectomy was well tolerated. Toxic effects were comparable to a historical cohort of patients receiving conventionally fractionated ...
Men with prostate cancer have a major decision to make: whether to get a lifesaving surgery. Radical prostatectomy, the ...
Gene signature predictor of dose-response to prostate radiation: Validation of PORTOS in phase III trials. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers Symposium. This ...
The optimal strategy for treating newly diagnosed high-risk prostate cancer remains unclear. More specifically, do these patients benefit more from radical prostatectomy or a radiotherapy-based ...
Up to 72% of patients with prostate cancer who undergo radical prostatectomy experience urinary incontinence in the first 3 months after surgery. Up to 72% of patients experience urinary incontinence ...
A new study reveals that some men who are diagnosed with "Grade Group one" (GG1) prostate cancer may actually be at higher risk than biopsy results suggest, according to research led by Weill Cornell ...
EDAP TMS SA announced the positive results of its Focal Ablation Versus Radical Prostatectomy (FARP) Study at the AUA Annual Meeting on April 27, 2025. The trial achieved its primary goal, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results